GlobeNewswire by notified

RAPS Euro Convergence 2023 highlights information transparency, MDR and IVDR transitions and more to a sold-out audience in Amsterdam

Share

Amsterdam, May 12, 2023 (GLOBE NEWSWIRE) -- RAPS Euro Convergence 2023 concluded on Friday, as a record 650-plus attendees gathered in Amsterdam for three days of learning and networking at the most comprehensive regulatory affairs conference in Europe.


Last year’s Euro Convergence, also in Amsterdam following two years of online conferences, set the record as RAPS’ largest event in Europe. This year’s conference exceeded that mark, with delegates from more than 36 countries across five continents and setting a new benchmark for RAPS European events.

“We saw last year how important it was for the profession to attend a conference in person,” said conference committee co-chair Siegfried Schmitt, vice president, technical at Parexel. “The sold-out attendance and energy this year truly reinforce the relevance and value of RAPS Euro Convergence. It's simply fantastic!”

RAPS Euro Convergence is the most comprehensive regulatory affairs conference in Europe, focusing on the latest developments in healthcare products in Europe and beyond—medical devices, pharmaceuticals and biologics, diagnostics, and digital health. Here are some highlights from this year’s record-setting event.

An opening plenary session dedicated to transparency in European medical safety information

Wednesday’s opening plenary session marked the official start of this year’s conference with a panel discussion during which the panelists agreed that safety information related to medical products in Europe should be accessible and presented in a way that it can be understood by the public.

They argued that information in the EUDAMED database for medical devices and the EU Clinical Trials Information System (CTIS) needs to be presented in such a way that patients have enough understanding to advocate for their own care. 

“Patient safety and access to data go hand in hand,” said Jet Schouten, an investigative journalist with the Dutch newspaper NRC.

Educational sessions with leading regulatory experts, health authorities and notified bodies

Euro Convergence 2023 featured more than 40 educational sessions with leading regulatory experts from around the world. Among the presenters were more than 30 representing health authorities or notified bodies from a diverse cross-section of organisations throughout Europe. Educational sessions covered a range of topics including MDR and IVDR transition and implementation, the EU CTR, interactions with health authorities and notified bodies, artificial intelligence and more.

Topic-specific tracks in pharmaceuticals, medical devices, IVDR and regulatory business enabled delegates to get in-depth learning. A “Conversations that Matter: Interactions with Health Authorities” session gave delegates an opportunity to ask direct questions to health authority and notified body representatives in an interactive discussion format.

The chance to reconnect with global regulatory colleagues

At RAPS’ largest-ever event in Europe, professionals had the opportunity to hear about vital regulatory updates and explore dynamic collaboration opportunities and essential professional development. In addition, the sold-out tabletop exhibits at RAPS Euro Convergence allowed delegates to meet with new business partners and discuss the latest innovations from across the industry.

“At the end of the day, nothing beats an event like this,” said conference committee co-chair Alex Laan, head of IVD notified body at BSI Group. “Delegates learn so much from each other and have so many valuable experiences in between and after the presentations, which is something you can really only do if you engage one another face-to-face.”

Chapter and local networking group (LNG) meet and greets enabled delegates to reconnect with old colleagues and build new connections for future collaboration. Nine local RAPS communities came together for in-person meetups, including RAPS’ recently-launched local networking groups in Spain and Portugal.

A robust agenda that went much further than educational sessions

The conference programme also included preconference workshops, poster presentations, sponsored sessions and networking events, including a networking dinner at the historic Kanarie Club. Delegates voted “Developing Guidelines for Medical 3D Printing in Various Scenarios: A Challenging Task?” by Nivedha Subramanian as the best poster.

“It is fantastic to see how much RAPS Euro Convergence has grown in our second year back in-person,” said RAPS Executive Director Bill McMoil. “RAPS is focused on listening to and creatively serving the European regulatory affairs community and, as a result, I expect RAPS Euro Convergence to continue its phenomenal growth in the years to come.”

After two years in Amsterdam, RAPS Euro Convergence is expanding to a larger venue and heading to the Berlin Congress Center on 6-8 May in 2024. Sign up here to stay informed.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of professionals involved with regulatory and quality for healthcare products, including medical devices, pharmaceuticals and biologics, diagnostics, and digital health. Founded in 1976 as a neutral, nonprofit organization, RAPS supports and elevates the regulatory profession with education and training, professional standards, publications, research, networking, career development, and other valuable resources. RAPS is home to the Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. The society is headquartered in suburban Washington, D.C., with chapters and affiliates worldwide. www.raps.org

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Investeringsselskabet Artha Optimum A/S - forløb af ordinær generalforsamling24.4.2024 14:55:09 CEST | pressemeddelelse

Selskabsmeddelelse nr. 05, 2024 Hellerup, 24. april 2024 GENERALFORSAMLINGSREFERAT Referat af ordinær generalforsamling i Investeringsselskabet Artha Optimum A/S, CVR. NR. 32 93 78 96 Onsdag, den 24. april 2024, kl. 10:00 Generalforsamlingen afholdtes på selskabets adresse Strandvejen 58, 2900 Hellerup Bestyrelsen udpegede advokat Klaus Lund til dirigent. Dirigenten konstaterede, med generalforsamlingens tilslutning, at generalforsamlingen var lovligt indvarslet og beslutningsdygtig i henhold til dagsordenen. Dagsorden: Bestyrelsens beretning om selskabets virksomhed i det forløbne år.Fremlæggelse af årsrapport til godkendelse.Beslutning om anvendelse af årets resultat.Valg af medlemmer til bestyrelsen.Valg af revisor.VedtægtsændringerEventuelt. 1. Bestyrelsens beretning om selskabets virksomhed i det forløbne år. Bestyrelsen aflagde sin beretning. Generalforsamlingen tog beretningen til efterretning. 2. Fremlæggelse af årsrapport til godkendelse. Årsrapporten for 2023 blev fremlagt og

Novo Nordisk A/S – Reduction of the share capital24.4.2024 14:48:49 CEST | Press release

Bagsværd, Denmark, 24 April 2024 – At Novo Nordisk’s Annual General Meeting on 21 March 2024, it was decided to reduce the company’s B share capital from DKK 343,512,800 to DKK 339,012,800 by cancellation of part of the company’s portfolio of own B shares equal to a nominal value of DKK 4,500,000 divided into 45,000,000 B shares of DKK 0.10 each. Today, Novo Nordisk has registered the implementation of the reduction of the share capital with the Danish Business Authority and cancelled B shares at a nominal value of DKK 4,500,000. After the reduction of the share capital, the company’s share capital is nominally DKK 446,500,000, which is divided into an A share capital of nominally DKK 107,487,200 and a B share capital of nominally DKK 339,012,800. The reduction of the share capital will not affect Novo Nordisk’s share repurchase programme, which will continue as previously announced. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our

cBrain takes lead within AI for government24.4.2024 14:48:40 CEST | Press release

Company Announcement no. 07/2024 cBrain takes lead within AI for government Copenhagen, April 24, 2024 cBrain (NASDAQ: CBRAIN) entered 2024 on the back of continued strong organic growth and solid earnings, reporting full-year 2023 results showing a 27% growth year-over-year and EBT (earnings before tax) of 34%. The first months of 2024 show continued business development in line with plans, winning new customers and projects in both Denmark and internationally. Consequently, cBrain maintains its expectations for 2024, forecasting full-year revenue growth of 20-25% and EBT (earnings before tax) of 24-30%. First quarter 2024 has been exciting for cBrain. While executing the growth plan, with a continued focus on F2 Climate Software as an international door opener and developing the F2-for-Partners concept, cBrain has in parallel developed a new F2 standard module for government Artificial Intelligence (AI), called F2 AI Assistant. F2 AI Assistant has been developed in close collaboratio

Vertex Selected to Join Oracle ISV Accelerator for SaaS Initiative24.4.2024 14:00:00 CEST | Press release

Vertex offers customers an optimized business operations and outcomes experience by integrating tax in and around Oracle Fusion Cloud Applications KING OF PRUSSIA, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions and a member of Oracle PartnerNetwork (OPN), today announced that it has been selected to join the Oracle Independent Software Vendor (ISV) Accelerator for SaaS Initiative. With expertise in Oracle Cloud Fusion Cloud Applications integrations, Vertex continues to leverage the power of contract and tax data to optimize customer operations and outcomes. "Building on our longstanding relationship with Oracle, we are thrilled to join the Oracle ISV Accelerator," said Bradd Wildstein, Vice President, Indirect Sales at Vertex, Inc. "Through this partnership, Vertex can now enhance our customers' finance and sales processes by integrating essential tax solutions into Oracle Fusion Application

Reminder: Program for the publication of Yara International ASA first quarter results 202424.4.2024 14:00:00 CEST | Press release

Yara International ASA first quarter 2024 results will be published on Friday, 26 April 2024 at 08:00 CEST. You can follow the presentation of first quarter results at 12:00 CEST. The presentation will be held in English. The report, presentation and webcast will be available at the above mentioned times at: https://yara.com/investor-relations/latest-quarterly-report/ There will also be a conference call at 13:00 CEST the same day with an opportunity to ask questions to Yara’s management. Please use the link to register for this session: https://registrations.events/direct/Q4I2875784 Registered conference call participants will receive a confirmation with a full list of available international dial-in numbers and a unique passcode. If you do not see the email in a few minutes after completed registration, please check the “junk mail” folder or “spam” folder in your email client. Please join the call 5-10 minutes prior to scheduled start time. Alternatively, it is possible to use the di

HiddenA line styled icon from Orion Icon Library.Eye